Aurora Cannabis (NASDAQ:ACB) Raised to “Strong-Buy” at Atb Cap Markets

Aurora Cannabis (NASDAQ:ACB) was upgraded by equities research analysts at Atb Cap Markets from a “hold” rating to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports.

ACB has been the topic of several other research reports. TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. TD Cowen began coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They issued a “buy” rating on the stock.

Aurora Cannabis Price Performance

ACB opened at $6.25 on Wednesday. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $342.86 million, a P/E ratio of -8.22 and a beta of 1.84. The stock has a 50-day moving average price of $4.24 and a 200-day moving average price of $5.16. Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35.

Aurora Cannabis (NASDAQ:ACB) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a negative net margin of 17.47% and a negative return on equity of 2.19%. Equities analysts predict that Aurora Cannabis will post -0.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. SBI Securities Co. Ltd. purchased a new position in shares of Aurora Cannabis during the fourth quarter valued at approximately $31,000. Cubist Systematic Strategies LLC bought a new position in shares of Aurora Cannabis in the 2nd quarter worth about $50,000. Wealthspire Advisors LLC bought a new stake in Aurora Cannabis during the fourth quarter worth about $149,000. Finally, Tidal Investments LLC grew its holdings in Aurora Cannabis by 2.7% in the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock worth $7,905,000 after purchasing an additional 34,988 shares during the period. Institutional investors own 47.63% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.